Press "Enter" to skip to content

New patent expiration for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF

Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF
Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF

Flonase Sensimist Allergy Relief is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

Drug patent litigation for FLONASE SENSIMIST ALLERGY RELIEF.

This drug has two hundred and sixty-four patent family members in forty-one countries.

The generic ingredient in FLONASE SENSIMIST ALLERGY RELIEF is fluticasone furoate. One supplier is listed for this compound. Additional details are available on the fluticasone furoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions